Steven M Grunberg

Steven M Grunberg

UNVERIFIED PROFILE

Are you Steven M Grunberg?   Register this Author

Register author
Steven M Grunberg

Steven M Grunberg

Publications by authors named "Steven M Grunberg"

Are you Steven M Grunberg?   Register this Author

44Publications

896Reads

14Profile Views

Chemotherapy-induced nausea and vomiting incidence and prevalence.

Am Soc Clin Oncol Educ Book 2012 :541-3

From the Division of Hematology/Oncology, University of Vermont, Burlington, VT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2012.32.45DOI Listing
April 2016

Emerging treatments in chemotherapy-induced nausea and vomiting.

Clin Adv Hematol Oncol 2013 Feb;11(2 Suppl 1):1-18; quiz 2 p following 18

The University of Vermont College of Medicine, Burlington, Vermont, USA.

View Article

Download full-text PDF

Source
February 2013

Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives.

J Natl Compr Canc Netw 2012 Feb;10(2):149-57

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2012.0018DOI Listing
February 2012

Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomiting.

Clin Adv Hematol Oncol 2011 Nov;9(11 Suppl 27):1-14; quiz 15-6

The West Clinic, Memphis, Tennessee, USA.

View Article

Download full-text PDF

Source
November 2011

Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement.

Support Care Cancer 2011 Mar 26;19 Suppl 1:S1-4. Epub 2010 May 26.

Division of Hematology-Oncology, Mel and Bren Simon Cancer Center, Indiana University, 535 Barnhill Room 473, Indianapolis, IN 46202-5289, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-010-0920-zDOI Listing
March 2011

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the art.

Support Care Cancer 2011 Mar 24;19 Suppl 1:S43-7. Epub 2010 Oct 24.

Division of Hematology/Oncology, University of Vermont College of Medicine, 89 Beaumont Avenue, Given Building E214, Burlington, VT 05405, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-010-1003-xDOI Listing
March 2011

Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients.

J Support Oncol 2010 Nov-Dec;8(6):242-51

Division of Quantitative Sciences, Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77230, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.suponc.2010.09.027DOI Listing
February 2011

Protocol for the examination of specimens from patients with primary non-small cell carcinoma, small cell carcinoma, or carcinoid tumor of the lung.

Arch Pathol Lab Med 2009 Oct;133(10):1552-9

Department of Pathology and Laboratory Medicine, Fletcher Allen Health Care, University of Vermont, Burlington, VT 05401-1473, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165-133.10.1552DOI Listing
October 2009

Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy.

Support Care Cancer 2009 May 27;17(5):589-94. Epub 2008 Nov 27.

Division of Hematology/Oncology, Vermont Cancer Center, 89 Beaumont Avenue-Given Bldg E214, Burlington, VT 05405, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-008-0535-9DOI Listing
May 2009

Obstacles to the implementation of antiemetic guidelines.

J Natl Compr Canc Netw 2009 May;7(5):601-5

Division of Hematology/Oncology, University of Vermont College of Medicine, Burlington, VT 05405, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2009.0040DOI Listing
May 2009

Evaluation of the relative importance of chemotherapeutic and antiemetic efficacy in various oncologic settings.

Support Care Cancer 2009 Apr 2;17(4):405-11. Epub 2008 Sep 2.

The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1650 New Orleans Street, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-008-0501-6
Publisher Site
http://dx.doi.org/10.1007/s00520-008-0501-6DOI Listing
April 2009

Giving permission.

J Clin Oncol 2008 Nov 27;26(33):5477-8. Epub 2008 Oct 27.

Division of Hematology/Oncology, Vermont Cancer Center, Burlington, VT 05405, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.18.7559DOI Listing
November 2008

Birth and re-birth.

Support Care Cancer 2008 Sep;16(9):979

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-008-0488-zDOI Listing
September 2008

Malignant mesothelioma following thoracic radiotherapy for lung cancer.

Lung Cancer 2007 Sep 1;57(3):410-3. Epub 2007 May 1.

Department of Medicine, University of Vermont College of Medicine, Vermont Cancer Center, 89 Beaumont Avenue, Given E-214, Burlington, VT 05405, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2007.03.016DOI Listing
September 2007

Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma.

Cancer Invest 2006 Dec;24(8):727-33

Division of Hematology/Oncology, University of Vermont College of Medicine, Burlington, Vermont, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/0735790060106233
Publisher Site
http://dx.doi.org/10.1080/07357900601062339DOI Listing
December 2006

Chemotherapy-induced nausea and vomiting: prevention, detection, and treatment--how are we doing?

J Support Oncol 2004 Jan-Feb;2(1 Suppl 1):1-10, inside back cover; quiz 11

Fletcher Allen Health Care, UHC Campus/St. Joseph 3400, 1 South Prospect Street, Burlington, VT 05401, USA.

View Article

Download full-text PDF

Source
December 2005

Management of patients receiving long-term treatment with mifepristone.

Fertil Steril 2005 Dec;84(6):1719-26

Institute of Hormone Research, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fertnstert.2005.05.056DOI Listing
December 2005

Phase I/II trial of paclitaxel and vinorelbine in advanced non-small cell lung cancer.

Cancer Invest 2005 ;23(5):392-8

Division of Hematology/Oncology, University of Vermont, Burlington, Vermont, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1081/cnv-67137DOI Listing
October 2005

New directions in supportive care.

Support Care Cancer 2005 Mar 10;13(3):135-7. Epub 2004 Dec 10.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-004-0742-yDOI Listing
March 2005

Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement.

Support Care Cancer 2005 Feb 9;13(2):112-6. Epub 2004 Oct 9.

Division of Hematology-Oncology, Indiana University School of Medicine, Indianapolis, IN 46202-5289, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-004-0704-4
Publisher Site
http://dx.doi.org/10.1007/s00520-004-0704-4DOI Listing
February 2005

New developments in the management of chemotherapy-induced emesis: do they impact on existing guidelines?

Oncology (Williston Park) 2004 Sep;18(10 Suppl 6):15-9

Department of Medicine, University of Vermont, Burlington, Vermont, USA.

View Article

Download full-text PDF

Source
September 2004

Aerorespiratory tract cancer in older patients.

Semin Oncol 2004 Apr;31(2):220-33

Division of Hematology/Oncology, The University of Vermont, UHC Campus, St Joseph 3400, 1 South Prospect Street, Burlington, VT 05401, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2003.12.032DOI Listing
April 2004

Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis.

Expert Opin Pharmacother 2003 Dec;4(12):2297-303

Division of Hematology/Oncology, University of Vermont, Burlington, Vermont 05401, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.4.12.2297DOI Listing
December 2003

The integral role of clinical research in clinical care.

N Engl J Med 2003 Apr;348(14):1386-8

Division of Hematology-Oncology, University of Vermont School of Medicine, Burlington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMsb025342DOI Listing
April 2003

Intensity of chemotherapy-induced emesis and overall survival as determinants of a global utility score.

Support Care Cancer 2002 Nov 2;10(8):624-9. Epub 2002 Aug 2.

Division of Hematology/Oncology, Fletcher Allen HealthCare, University of Vermont, UHC Campus/St. Joseph 3400, 1 South Prospect Street, Burlington, VT 05401, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-002-0381-0DOI Listing
November 2002

Antiemetic guidelines: creating a more practical treatment approach.

Support Care Cancer 2002 Oct 21;10(7):519-22. Epub 2002 Feb 21.

University of Texas Health Science Center at San Antonio, Pharmacotherapy--MSC 6220, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-001-0335-yDOI Listing
October 2002

Optimal use of antiemetics in the outpatient setting.

Oncology (Williston Park) 2002 Oct;16(10):1401-7; discussion 1407-8, 1412

University of Vermont, Burlington, USA.

View Article

Download full-text PDF

Source
October 2002